Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2026-02-25 @ 4:39 PM
Study NCT ID:
NCT02725593
Status:
COMPLETED
Last Update Posted:
2022-02-23
First Post:
2016-03-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06-22
Start Date Type:
ACTUAL
Primary Completion Date:
2020-04-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-04-06
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-29
First Submit QC Date:
None
Study First Post Date:
2016-04-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-10-02
Results First Submit QC Date:
None
Results First Post Date:
2020-12-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-28
Last Update Post Date:
2022-02-23
Last Update Post Date Type:
ACTUAL